Kennedy has been most vocal about the FDA, an agency that oversees nearly $3 trillion in medicines, food and tobacco products ...

In a letter to DCGI, industry body the Indian Pharmaceutical Alliance (IPA) says companies should be given 30 days’ notice to ...

RFK Jr.’s anti-industry and anti-vaccine rhetoric has been strong, but experts wonder whether those words will turn into ...

President-elect Donald Trump taps Robert F. Kennedy Jr. to lead U.S. Health and Human Services Department (HHS). Vaccine ...

Expediting the review process allows for appropriately timed advice and ... This represents a dynamic and ongoing challenge ...

FELIQS plans to conduct a Phase 1b/2 study of FLQ-101 (tROPhy-1 study) both in the US and Japan in the first quarter of 2025.

National public health and medical association leaders express concern over nomination of Robert F. Kennedy Jr. to lead vast ...

The new director at the FDA overseeing medical devices will confront criticisms about hasty approvals as she ushers in ...

From drug pricing to reforming the drug regulatory process, Trump’s re-election has plenty of implications for the pharma ...

The integration of AI into drug submission and approval processes signifies a shift towards more efficient pharmaceutical development. The potential benefits are substantial, including faster ...

The transition period between when voters select a presidential candidate and when that person takes office “is almost ...

The rise of antibody therapeutics is transforming drug discovery, providing highly specific treatments for complex diseases ...